← Back to Clinical Trials
Recruiting NCT04945304

NCT04945304 9-Step Magnetic Bariatric Revisional Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04945304
Status Recruiting
Phase
Sponsor Unidad Internacional de Cirugia Bariatrica y Metabolica
Condition Bariatric Surgery Candidate
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2021-05-31
Primary Completion 2026-10-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
magnetic bariatric surgeryMagnetic gastric bypass

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500 participants in total. It began in 2021-05-31 with a primary completion date of 2026-10-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

RYGB represents one of the best alternatives for weight loss in obese patients achieving a weight loss of up to 60% and a resolution of comorbidities of 70%. Revision surgery contemplates multiple techniques including the conversion from one surgical technique to another, structural changes to the primary technique, among others. GERD is now a long-term problem for patients who have undergone LGS. RYGB is one of the best techniques to resolve this problem.

Eligibility Criteria

Inclusion Criteria: * Older than 18 years * Candidate to bariatric surgery * Obesity * BMI Greater than 30 kg/m2 Exclusion Criteria: * Uncontrolled co-morbidities * patients with pacemakers, defibrillators, or other electromedical implants * Abnormal coagulation blood tests * Patients with hepatic diseases

Contact & Investigator

Central Contact

Guillermo Borjas, MD. PhD

✉ drguillermoborjas@hotmail.com

📞 4146863041

Principal Investigator

Guillermo Borjas, MD. PhD

PRINCIPAL INVESTIGATOR

International Unit of Bariatric and Metabolic Surgery

Frequently Asked Questions

Who can join the NCT04945304 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Bariatric Surgery Candidate. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04945304 currently recruiting?

Yes, NCT04945304 is actively recruiting participants. Contact the research team at drguillermoborjas@hotmail.com for enrollment information.

Where is the NCT04945304 trial being conducted?

This trial is being conducted at Maracaibo, Venezuela.

Who is sponsoring the NCT04945304 clinical trial?

NCT04945304 is sponsored by Unidad Internacional de Cirugia Bariatrica y Metabolica. The principal investigator is Guillermo Borjas, MD. PhD at International Unit of Bariatric and Metabolic Surgery. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology